Freely-fed, female, rats were trained in a two-lever, delay-discounting task: one lever delivered a single chocolate-flavoured pellet immediately and the other a three-pellet reward after increasing delay (0, 4, 8, 16, 32 s). Rats were divided into two groups (i.e. binge-eating rats given irregular, limited access to chocolate in addition to normal chow and controls maintained on normal chow). Both groups exhibited increased preference for the immediate reward as the delay interval was lengthened. The discounting rate was significantly greater in binge-eating rats than non-binge-eating controls, especially as the behaviour became more established indicating that increased impulsivity and intolerance of delayed reward are part of the psychopathology of binge-eating. Lisdexamfetamine (0.8 mg/kg, orally (d-amphetamine base)) reversed the reduced preference of binge-eating rats for larger rewards at delay intervals of 4 s, 8 s and 32 s and across all sessions. Lisdexamfetamine-treated binge-eating rats consumed the same number of pellets as vehicle-treated, binge-eating rats and non-binge-eating controls eliminating the possibility lisdexamfetamine’s actions on appetite or satiety mediated its effects on operant responding for food pellets in delay-discounting. In summary, binge-eating rats showed increased impulsive choice compared with non-binge-eating controls that was reversed by lisdexamfetamine, complementing results showing lisdexamfetamine reduced impulsiveness scores in patients with binge-eating disorder.
AlessiSMPetryNM (2003) Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav Processes64: 345–354.
2.
CardinalRNRobbinsTWEverittBJ (2000) The effects of d-amphetamine, chlordiazepoxide, α-flupenthixol and behavioural manipulations on choice of signaled and unsignalled delayed reinforcement in rats. Psychopharmacology152: 362–375.
3.
CheethamSCGosdenJProwMR. (2014) Binge-eating behaviour produces alterations in dopaminergic neurochemistry in the brains of rats. Soc Neurosci abstract 233.04.
4.
CitromeL (2015) Lisdexamfetamine for binge eating disorder in adults: A systematic review of the efficacy and safety profile for this newly approved indication – what is the number needed to treat, number need to harm and the likelihood to be helped or harmed?Int J Clin Pract69: 410–421.
5.
CollesSLDixonJBO’BrienPE (2008) Loss of control is central to psychological disturbance associated with binge eating disorder. Obesity16: 608–614.
6.
DaiZHarrowS-ESongX. (2013) Gambling, delay, and probability discounting in adults with and without ADHD. J Atten Disord20: 968–978.
7.
DavisCPatteKCurtisC. (2010) Immediate pleasures and future consequences. A neuropsychological study of binge eating and obesity. Appetite54: 208–213.
8.
de ZwaanMMitchellJESeimHC. (1994) Eating related and general psychopathology in obese females with binge eating disorder. Int J Eat Disord15: 43–52.
9.
DeckerJHFignerBSteinglassJE (2015) On weight and waiting: Delay discounting in anorexia nervosa pretreatment and post-treatment. Biol Psychiatry78: 606–614.
10.
DickinsonKNorthTJTelfordG. (2001) Determination of body composition in conscious adult female Wistar rats utilising total body electrical conductivity (TOBEC). Physiol Behav74: 425–433.
11.
EvendenJLRyanCN (1996) The pharmacology of impulsive behaviour in rats: The effects of drugs in response choice with varying delays of reinforcement. Psychopharmacology128: 161–170.
12.
FairburnCGCooperZDollHA. (2000) The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry57: 659–665.
GalantiKGluckMEGeliebterA (2007) Test meal intake in obese binge eaters in relation to impulsivity and compulsivity. Int J Eat Disord40: 727–732.
15.
GearhardtANWhiteMAPotenzaMN (2011) Binge eating disorder and food addiction. Curr Drug Abuse Rev4: 201–207.
16.
GoldschmidtABLe GrangeDPowersP. (2011) Eating disorder symptomatology in normal-weight vs. obese individuals with binge-eating disorder. Obesity19: 1515–1518.
17.
HalfordJCWanninayakeSCBlundellJC (1998) Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav61: 159–168.
18.
HealDJJaggerE (2005). Development, regulatory and marketing challenges for novel anti-obesity therapies. In: AntelJFinerNHealD. (eds) Obesity and Metabolic Disorders. Amsterdam: IOS Press, pp. 73–91.
19.
HealDJGoddardSBrammerRJ. (2016) Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward/punished responding conflict model. J Psychopharmacol30: 662–675.
20.
HealDJHallamMProwMR. (2017) Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats – possible relevance in the psychopathology and treatment of binge-eating disorder. J Psychopharmacol, 31: 770–783.
21.
HealDJVickersSPHackettD. (2013) Metabolic effects of lisdexamfetamine in a rat model of human obesity with insulin resistance. Proceedings of the 26th ECNP Congress, Barcelona P.1.g.032. Available at: www.ecnp.eu (accessed 13 October 2013).
22.
HoekHWVan HoekenD (2003) Review of the prevalence and incidence of eating disorders. Int J Eat Disord34: 383–396.
23.
HudsonJIHiripiEPopeHGJr. (2007) The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry61: 348–358.
24.
HutsonPHPennickMSeckerR (2014) Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: A novel d-amphetamine pro-drug. Neuropharmacol87: 41–50.
25.
LawrenceKAAllenJSChanenAM (2010) Impulsivity in borderline personality disorder: Reward-based decision-making and its relationship to emotional distress. J Pers Disord24: 786–799.
26.
McElroySLHudsonJFerreira-CornwellMC. (2016a) Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: Results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology41: 1251–1260.
27.
McElroySLMitchellJEWilfleyD. (2015) Efficacy and safety of lisdexamfetamine dimesylate for treatment of adults with moderate to severe binge eating disorder: A randomized, double-blind, placebo-controlled trial. JAMA Psychiatry72: 235–246.
28.
McElroySLMitchellJEWilfleyD. (2016b). Lisdexamfetamine dimesylate effects on binge eating behaviour and obsessive-compulsive and impulsive features in adults with binge eating disorder. Eur Eat Disord Rev24: 223–231.
29.
MaguireDRHensonCFranceCP (2014) Effects of amphetamine on delay discounting in rats depend upon the manner in which delay is varied. Neuropharmacology87: 173–179.
30.
MashebRMGriloCMBrondoloE (1999) Shame and its psychopathologic correlates in two women’s health problems: Binge eating disorder and vulvodynia. Eat Weight Disord4: 187–193.
31.
MattinglyGWeislerRDirksB. (2012) Attention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylate. Innov Clin Neurosci9: 22–30.
MoleTBIrvineMAWorbeY. (2015) Impulsivity in disorders of food and drug misuse. Psychol Med45: 771–782.
34.
NasserJAGluckMEGeliebterA (2004) Impulsivity and test meal intake in obese binge eating women. Appetite43: 303–307.
35.
PetryNM (2002) Discounting of delayed rewards in substance abusers: Relationship to antisocial personality disorder. Psychopharmacology162: 425–432.
36.
QianJHuQWanY. (2013) Prevalence of eating disorders in the general population: A systematic review. Shanghai Arch Psychiatry25: 212–223.
37.
SchagKSchonleberJTeufelM. (2013) Food-related impulsivity in obesity and binge eating disorder: A systematic review. Obes Rev14: 477–495.
38.
StanisJJAvilaHMWhiteMD. (2008) Dissociation between long-lasting behavioural sensitization to amphetamine and impulsive choice in rats performing a delay-discounting task. Psychopharmacology199: 539–548.
39.
StojekMMFischerSMurphyCM. (2014) The role of impulsivity traits and delayed reward discounting in dysregulated eating and drinking among heavy drinkers. Appetite80: 81–88.
40.
SvaldiJNaumannETrentowskaM. (2014) General and food-specific inhibitory deficits in binge eating disorder. Int J Eat Disord47: 534–542.
41.
TannoTMaguireDRHensonC. (2014) Effects of amphetamine and methylphenidate on delay discounting in rats: Interactions with order of delay presentation. Psychopharmacology231: 85–95.
42.
TaraziFIChoiYKGosdenJ. (2015) Reduced expression of GAD65/67 mRNA and dopamine D1 and D2 receptors in binge-eating rats. In: Proceedings of the 54th annual meeting of the American College of Neuropsychopharmacology, Hollywood, FL, 6–10 December.
43.
TedfordSEPersonsALNapierTC (2015) Dopaminergic lesions of the dorsolateral striatum in rats increase delay-discounting in an impulsive choice task. PLoS One10: e0122063.
44.
van GaalenMMvan KotenRSchoffelmeerANM. (2006) Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry60: 66–73.
45.
VannucciATheimKRKassAE. (2013) What constitutes clinically significant binge eating? Association between binge features and clinical validators in college-age women. Int J Eat Disord46: 226–232.
46.
VickersSPHackettDMurrayF. (2015) Effects of lisdexamfetamine in a rat model of binge-eating. J Psychopharmacol29: 1290–1307.
47.
VickersSPJacksonHCCheethamSC (2011) The utility of animal models to evaluate novel anti-obesity agents. Br J Pharmacol164: 1248–1262.
48.
WeislerRHAdlerLAKollinsSH. (2014) Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: The effects of age and sex in pivotal trials of lisdexamfetamine dimesylate. Neuropsychiatr Dis Treat10: 1–12.
49.
WinstanleyCA (2011) The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol164: 1301–1321.
50.
WinstanleyCADalleyJWTheobaldDE. (2003) Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology170: 320–331.
51.
WinstanleyCATheobaldDEHDalleyJW. (2005) Interactions between serotonin and dopamine in the control of impulsive choice in rats: Therapeutic implications for impulse control disorders. Neuropsychopharmacology30: 669–682.
52.
WuMGielKESkundeM. (2013) Inhibitory control and decision making under risk in bulimia nervosa and binge-eating disorder. Int J Eat Disord46: 721–728.
